Skip to main content

APLS

Apellis Pharmaceuticals, Inc.

Company with tickers: APLS

CIK
1492422
CUSIP
03753U106
Shares Outstanding
128,021,277
13F Activity (30d)
164 filings 153 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 312
Total Value: $5,151,588,027
Total Shares: 128,053,398
Showing 1–100 of 329 holdings by value · page 1 of 4

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 310 13F filers · Δ vs Dec 31, 2025
Top Holder
11.2%
Sep 2023 → Mar 2026 · range 9.0% – 13.7%
−0.7 pts
Top 5
32.4%
Sep 2023 → Mar 2026 · range 32.4% – 45.5%
−11.5 pts
Top 10
50.2%
Sep 2023 → Mar 2026 · range 50.2% – 60.2%
−8.2 pts
HHI
346
Sep 2023 → Mar 2026 · range 346 – 534
Broadly held−152

Quarterly Activity

vs Dec 31, 2025
New
154
Increased
65
Decreased
60
Sold Out
73
Unchanged
33
Holder count: +81
Institutional value: +426.9%
Shares held: +229.0%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 329
Export CSV
Holder Value (USD) % of 13F Shares Open